Literature DB >> 4555783

Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.

R L Lerner, D Porte.   

Abstract

Previous observations in normal subjects have suggested that when 5-g glucose pulses (P) were given in the following sequence: before (P1) and 45 min after beginning a 300 mg/min glucose infusion (P2); during the 20th hr (P3) and 1 hr after the infusion was stopped (P4); the insulin responses were consistent with a simple two-pool model. One pool is a readily available small storage pool which is refilled by a second, larger, more slowly responding pool that controls basal and steady-state insulin output. The identical protocol was employed to evaluate the insulin responses in 13 nonobese diabetic subjects. DIABETICS HAD BASAL INSULIN LEVELS INDISTINGUISHABLE FROM NORMALS (DIABETICS: 10.7+/-4; normals: 10.7+/-5, mean +/-SD, muU/ml), but had significantly elevated basal glucose levels (diabetics: 161+/-27; normals: 88+/-7, mg/100 ml, P < 0.05). The mean early insulin response (3-5 min Delta IRI) after a 5 g glucose pulse (P1) was significantly diminished in diabetics (diabetics 6.4+/-9; normals: 32.5+/-14, muU/ml, P < 0.01) consistent with a defective storage pool output. The glucose disappearance rate, K(G), decreased in parallel with the early insulin response and the slope of the regression line between these two variables was virtually identical with that calculated from 16 normal subjects. Similar to normal subjects, during the short glucose infusion, the acute insulin response to P2 was diminished in diabetics (P < 0.02). In normal subjects after 20 hr of infusion, the rapid insulin responses to P3 are restored to the preinfusion P1 values, and 1 hr after the infusion was stopped, the responses to P4 are increased twofold (P < 0.001). Diabetics, however, demonstrated decreased early responses to P3 (P < 0.001) and no increased response to P4. In contrast to the diminished acute insulin responses to glucose pulses, diabetics have steady-state insulin levels after 20 hr of glucose infusion similar to those of normal subjects (diabetics: 25.7+/-13; normals: 32.5+/-14, muU/ml). Thus both basal and steady-state insulin levels of diabetics were comparable with those of normal subjects, which suggest that although the rapid insulin response from the storage pool output is defective in diabetics, the more slowly responding pool is intact.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4555783      PMCID: PMC292309          DOI: 10.1172/JCI106963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  EFFECT OF GLUCOSE DOSE UPON INTRAVENOUS GLUCOSE TOLERANCE IN HEALTH AND IN DIABETES.

Authors:  J A MOORHOUSE; J STEINBERG; B B TESSLER
Journal:  J Clin Endocrinol Metab       Date:  1963-11       Impact factor: 5.958

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate.

Authors:  R L Lerner; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

4.  Portal vein insulin concentrations in diabetic subjects.

Authors:  W G Blackard; N C Nelson
Journal:  Diabetes       Date:  1971-05       Impact factor: 9.461

5.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

6.  The relationship between endogenous serum insulin concentration and glucose uptake in the forearm muscles of nondiabetics.

Authors:  N J Christensen; H Orskov
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

7.  Plasma insulin: fluctuations in the "big" insulin component in man after glucose and other stimuli.

Authors:  P Gorden; J Roth
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

8.  Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors.

Authors:  P Gorden; B Sherman; J Roth
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  Glucose dynamics in normal subjects and diabetic patients before and after a glucose load.

Authors:  N Forbath; G Hetenyi
Journal:  Diabetes       Date:  1966-11       Impact factor: 9.461

10.  Insulin responses to glucose: evidence for a two pool system in man.

Authors:  D Porte; A A Pupo
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  20 in total

1.  A simulation model of extracellular glucose distribution in the human body.

Authors:  J Tiran; K R Galle; D Porte
Journal:  Ann Biomed Eng       Date:  1975-03       Impact factor: 3.934

2.  The role of carbohydrate and oral agents in the treatment of diabetes mellitus.

Authors:  W D Odell
Journal:  Calif Med       Date:  1973-10

3.  An optimal control model of diabetes mellitus.

Authors:  G W Swan
Journal:  Bull Math Biol       Date:  1982       Impact factor: 1.758

4.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

Authors:  R N Bergman; L S Phillips; C Cobelli
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

5.  Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

Authors:  J P Hosker; D R Matthews; A S Rudenski; M A Burnett; P Darling; E G Bown; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Paradoxical inhibition of insulin secretion by glucose in non-insulin-dependent diabetic patients.

Authors:  M Linstow; K J Mikines; F Dela; H Galbo
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

7.  I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects.

Authors:  R Prando; R Cordera; A De Micheli; M Maiello; P Odetti; G Viviani; L Corsi; L Adezati
Journal:  Acta Diabetol Lat       Date:  1978 Sep-Dec

8.  An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes.

Authors:  M A Permutt; K Kakita; P Malinas; I Karl; S Bonner-Weir; G Weir; S J Giddings
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

9.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

10.  Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.

Authors:  Y T Kruszynska; D S Harry; R N Bergman; N McIntyre
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.